Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms

Gut

Volumn 69, Issue 6, 2020, Pages 1002-1009

  Jin, Xi ^a   Lian, Jiang Shan ^b   Hu, Jian Hua ^b   Gao, Jianguo ^a   Zheng, Lin ^b   Zhang, Yi Min ^b   Hao, Shao Rui ^b   Jia, Hong Yu ^b   Cai, Huan ^b   Zhang, Xiao Li ^b   Yu, Guo Dong ^b   Xu, Kai Jin ^b   Wang, Xiao Yan ^b   Gu, Jue Qing ^b   Zhang, Shan Yan ^b   Ye, Chan Yuan ^b   Jin, Ci Liang ^b   Lu, Ying Feng ^b   Yu, Xia ^b   Yu, Xiao Peng ^b   Huang, Jian Rong ^b   Xu, Kang Li ^a   Ni, Qin ^b   Yu, Cheng Bo ^b   Zhu, Biao ^b   Li, Yong Tao ^b   Liu, Jun ^b   Zhao, Hong ^b   Zhang, Xuan ^b   Yu, Liang ^b   Guo, Yong Zheng ^b   Su, Jun Wei ^b   Tao, Jing Jing ^b   Lang, Guan Jing ^b   Wu, Xiao Xin ^b   Wu, Wen Rui ^b   Qv, Ting Ting ^b   Xiang, Dai Rong ^b   Yi, Ping ^b   Shi, Ding ^b   Chen, Yanfei ^b   Ren, Yue ^a   Qiu, Yun Qing ^b   Li, Lan Juan ^b   Sheng, Jifang ^b   Yang, Yida ^a,b   more..

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

diarrhoea; infectious disease

Indexed keywords

6 N METHYLADENOSINE; ALPHA INTERFERON; ANGIOTENSIN CONVERTING ENZYME 2; ANTIBIOTIC AGENT; ARBIDOL; CORTICOSTEROID; GLUCOSE; LACTATE DEHYDROGENASE; LOPINAVIR PLUS RITONAVIR;

ADULT; AGE; ARTICLE; BIOINFORMATICS; CHINA; CLINICAL FEATURE; CORONAVIRUS DISEASE 2019; DEMOGRAPHY; DIARRHEA; DISEASE SEVERITY; DYSPNEA; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; GENE MUTATION; HEADACHE; HOSPITAL PATIENT; HUMAN; INCUBATION TIME; LABORATORY TEST; LIVER DISEASE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NAUSEA; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN METHYLATION; REAL TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; RISK FACTOR; SEQUENCE ANALYSIS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SPUTUM; VOMITING; BETACORONAVIRUS; CORONAVIRUS INFECTION; GASTROINTESTINAL TRACT; LABORATORY TECHNIQUE; PANDEMIC; PATHOPHYSIOLOGY; VIROLOGY; VIRUS PNEUMONIA;

ADULT; BETACORONAVIRUS; CHINA; CLINICAL LABORATORY TECHNIQUES; CORONAVIRUS INFECTIONS; FEMALE; GASTROINTESTINAL TRACT; HUMANS; MALE; MIDDLE AGED; PANDEMICS; PNEUMONIA, VIRAL; RISK FACTORS;

EID: 85082407950     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2020-320926     Document Type: Article

References (29)

1. Lu H, Stratton CW, Tang Y-W. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol 2020;92:401-2.
2. Zhao S, Lin Q, Ran J, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. Int J Infect Dis 2020;92:214-7.
3. Bogoch II, Watts A, Thomas-Bachli A, et al. Potential for global spread of a novel coronavirus from China. J Travel Med 2020;27.
4. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507-13.
5. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506.
6. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020. doi:10.1056/NEJMoa2001316. [Epub ahead of print: 29 Jan 2020].
7. Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet 2020;395:689-97.
8. Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395:565-74.
9. Wan Y, Shang J, Graham R, et al. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol 2020;94. doi:10.1128/JVI.00127-20. [Epub ahead of print: 17 Mar 2020].
10. Zhao S, Zhuang Z, Ran J, et al. The association between domestic train transportation and novel coronavirus (2019-nCoV) outbreak in China from 2019 to 2020: a data-driven correlational report. Travel Med Infect Dis 2020;33:101568.
11. Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med 2020;382:929-36.
12. Zhang H, Kang Z, Gong H, et al. The digestive system is a potentila route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes. bioRxiv 2020:927806.
13. WHO. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance. Available: https://www. who. int/internal-publications-detail/clinical-management-of-severe-acute-respiratoryinfection-when-novel-coronavirus-( ncov)-infection-is-suspected [Accessed 30 Jan2020].
14. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020.
15. Li G, Fan Y, Lai Y, et al. Coronavirus infections and immune responses. J Med Virol 2020;92:424-32.
16. Xia J, Tong J, Liu M, et al. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-C oV-2 infection. J Med Virol 2020. doi:10.1002/jmv.25725. [Epub ahead of print: 26 Feb 2020].
17. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020. doi:10.1001/jama.2020.1585. [Epub ahead of print: 07 Feb 2020].
18. Fang Dan MJ, Guan J, Wang M, et al. Manifestations of digestive system in hospitalized patients with novel coronavirus pneumonia in Wuhan, China: a single-center, descriptive study. Chin J Dig 2020.
19. Roundtree IA, Evans ME, Pan T, et al. Dynamic RNA modifications in gene expression regulation. Cell 2017;169:1187-200.
20. Wang X, Lu Z, Gomez A, et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature 2014;505:117-20.
21. Kennedy EM, Bogerd HP, Kornepati AVR, et al. Posttranscriptional m(6)A Editing of HIV-1 mRNAs Enhances Viral Gene Expression. Cell Host Microbe 2016;19:675-85.
22. Gokhale NS, McIntyre ABR, McFadden MJ, et al. N6-Methyladenosine in Flaviviridae viral RNA genomes regulates infection. Cell Host Microbe 2016;20:654-65.
23. Karikó K, Buckstein M, Ni H, et al. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 2005;23:165-75.
24. Courtney DG, Kennedy EM, Dumm RE, et al. Epitranscriptomic enhancement of influenza A virus gene expression and replication. Cell Host Microbe 2017;22:377-86.
25. Schäfer A, Baric RS. Epigenetic landscape during coronavirus infection. Pathogens 2017;6. doi:10.3390/pathogens6010008. [Epub ahead of print: 15 Feb 2017].
26. Chen Y, Guo D. Molecular mechanisms of coronavirus RNA capping and methylation. Virol Sin 2016;31:3-11.
27. Menachery VD, Yount BL, Debbink K, et al. A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. Nat Med 2015;21:1508-13.
28. Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol 2017;39:529-39.
29. Pan Y, Zhang D, Yang P, et al. Viral load of SARS-C oV-2 in clinical samples. Lancet Infect Dis 2020. doi:10.1016/S1473-3099(20)30113-4. [Epub ahead of print: 24 Feb 2020].